3838
B. Madhav et al. / Tetrahedron Letters 53 (2012) 3835–3838
19. Dalip, K.; Kumar, N. M.; Patel, G.; Gupta, S.; Varma, R. S. Tetrahedron Lett. 2011,
52, 1983.
of 2,2-dibromo-1-phenylethanone, ability to proceed without
acids/bases or additives, under milder environmental friendly con-
ditions. This protocol will be an interesting addition to the green
chemistry (see Table 4).
20. (a) Murthy, S. N.; Madhav, B.; Kumar, A. V.; Rao, K. R.; Nageswar, Y. V. D. Helv.
Chim. Acta 2009, 92, 2118; (b) Murthy, S. N.; Madhav, B.; Kumar, A. V.; Rao, K.
R.; Nageswar, Y. V. D. Tetrahedron 2009, 65, 5251; (c) Madhav, B.; Murthy, S. N.;
Reddy, V. P.; Rao, K. R.; Nageswar, Y. V. D. Tetrahedron Lett. 2009, 50, 6025; (d)
Murthy, S. N.; Madhav, B.; Reddy, V. P.; Nageswar, Y. V. D. Tetrahedron Lett.
2010, 51, 3649; (e) Shankar, J.; Karnakar, K.; Srinivas, B.; Nageswar, Y. V. D.
Tetrahedron Lett. 2010, 51, 3938; (f) Murthy, S. N.; Madhav, B.; Nageswar, Y. V.
D. Tetrahedron Lett. 2010, 51, 5252; (g) Ramesh, K.; Murthy, S. N.; Nageswar, Y.
V. D. Tetrahedron Lett. 2011, 52, 2362; (h) Ramesh, K.; Murthy, S. N.; Karnakar,
K.; Nageswar, Y. V. D. Tetrahedron Lett. 2011, 52, 3937; (i) Ramesh, K.; Murthy,
S. N.; Karnakar, K.; Nageswar, Y. V. D. Tetrahedron Lett. 2011, 52, 4734; (j) Anil
Kumar, B. S. P.; Madhav, B.; Harsha Vardhan Reddy, K.; Nageswar, Y. V. D.
Tetrahedron Lett. 2011, 52, 2862.
Acknowledgments
We thank the CSIR, New Delhi, India, for fellowships to B.M.,
S.N.M., B.S.P. and the UGC for a fellowship to K.R.
Supplementary data
21. (a) Paul, S.; Gupta, V.; Gupta, R.; Loupy, A. Tetrahedron Lett. 2003, 44, 439; (b)
Valeria, C.; Pierluca, G.; Adriano, S.; Barbara, F. Adv. Synth. Catal. 2005, 347,
1341; (c) Ye, C.; Shreeve, J. M. J. Org. Chem. 2004, 69, 8561.
Supplementary data associated with this article can be found, in
22. General procedure: b-Cyclodextrin (10 mol %) was dissolved in water (15 ml) at
70 °C and phenylacetylene (1.0 mmol) was added followed by NBS. After
10 min, thiourea (1.0 mmol) was added to this reaction mixture and stirred at
70 °C until the reaction was complete (Table 1). The mixture was extracted
with ethyl acetate, and the extract was filtered. The organic layer was washed
with water and dried over anhydrous Na2SO4, the solvent was removed under
reduced pressure, and the resulting crude product was further purified by
column chromatography using hexane and EtOAc as eluent to give the title
compound. The aqueous layer was cooled to 5 °C to recover b-CD by filtration.
This b-CD was recycled without any loss of activity.
23. Data for representative examples: 4-(p-Tolyl)thiazol-2-amine (Table 2, entry 2):
Solid, mp 135–137 °C 1H NMR (CDCl3/DMSO-d6, 300 MHz): d 7.60–7.58 (m,
2H), 7.14-7.11 (m, 2H), 6.57 (s, 1H), 5.28 (br s, 2H), 2.35 (s, 3H); (CDCl3/DMSO-
d6, 200 MHz): d 131.2, 128.3, 126.6, 126.4, 126.0, 125.2, 123.6, 27.3; ESI-MS (m/
z): 191(M+H)+. Anal. Calcd for (C10H10N2S): C, 63.13; H, 5.30; N, 14.72; S, 16.85.
Found C, 63.01; H, 5.25; N, 14.65; S, 16.78.
References and notes
1. De Souza, M. V. N. J. Sulfur Chem. 2005, 26, 429.
2. (a) Casar, Z.; Majcen-Le Marechal, A.; Lorey, D. New J. Chem. 2003, 27, 1622; (b)
Koketsu, M.; Ishihara, H. Curr. Org. Chem. 2003, 7, 175; (c) Duddeck, H.;
Bradenahl, R.; Stefaniak, L.; Jazwinski, J.; Kamienski, B. Magn. Reson. Chem.
2001, 39, 709; (d) Archer, S.; McGarry, R. J. Heterocycl. Chem. 1982, 19, 1245.
3. Koketsu, M.; Choi, S. Y.; Ishihara, H.; Lim, B. O.; Kim, H.; Kim, S. Y. Chem. Pharm.
Bull. 2002, 50, 1594.
4. (a) Goldstein, B. M.; Kennedy, S. D.; Hennen, W. J. J. Am. Chem. Soc. 1990, 112,
8265. and references cited therein; (b) Shafiee, A.; Khashayarmanesh, Z.;
Kamal, F. J. Sci. Islam. Repub. Iran 1990, 1, 11; (c) Shafiee, A.; Shafaati, A.;
Khamench, B. H. J. Heterocycl. Chem. 1989, 26, 709.
5. Sekhiguchi, A.; Nishina, A.; Kimura, H.; Fukumoto, R.-H.; Koichi, K.; Ishihara, H.;
Koketsu, M. Chem. Pharm. Bull. 2005, 53, 1439.
6. Lewis, J. R. Nat. Prod. Rep. 1999, 16, 389.
7. Patt, W. C.; Hamilton, H. W.; Taylor, M. D.; Ryan, M. J.; Taylor, D. G., Jr.;
Connolly, C. J. C.; Doharty, A. M.; Klutchko, S. R.; Sircar, I.; Steinbaugh, B. A.;
Bately, B. L.; Painchand, C. A.; Rapundalo, S. T.; Michniewicz, B. M.; Olzon, S. C. J.
J. Med. Chem. 1992, 35, 2562.
8. Jaen, J. C.; Wise, L. D.; Caprathe, B. W.; Tecle, H.; Bergmeier, S.; Humblet, C. C.;
Heffner, T. G.; Meltzner, L. T.; Pugsley, T. A. J. Med. Chem. 1990, 33, 311.
9. (a) Haviv, F.; Ratajczyk, J. D.; DeNet, R. W.; Kerdesky, F. A.; Walters, R. L.;
Schmidt, S. P.; Holms, J. H.; Young, P. R.; Carter, G. W. J. Med. Chem. 1988, 31,
1719; (b) Clemence, F.; Marter, O. L.; Delevalle, F.; Benzoni, J.; Jouanen, A.;
Jouquey, S.; Mouren, M.; Deraedt, R. J. Med. Chem. 1988, 31, 1453.
10. Hargrave, K. D.; Hess, F. K.; Oliver, J. T. J. Med. Chem. 1983, 26, 1158.
11. Tsuji, K.; Ishikawa, H. Bioorg. Med. Chem. Lett. 1994, 4, 1601.
12. Bell, F. W.; Cantrell, A. S.; Hoberg, M.; Jaskunas, S. R.; Johansson, N. G.; Jordon,
C. L.; Kinnick, M. D.; Lind, P.; Morin, J. M., Jr.; Noreen, R.; Oberg, B.; Palkowitz, J.
A.; Parrish, C. A.; Pranc, J.; Zhang, H.; Zhou, X.-X. J. Med. Chem. 1995, 38, 4929.
13. Fink, B. A.; Mortensen, D. S.; Stauffer, S. R.; Aron, Z. D.; Katzenellenbogen, J. A.
Chem. Biol. 1999, 6, 205.
14. Van Muijlwijk-Koezen, J. E.; Timmerman, H.; Vollinga, R. C.; Von Drabbe
Kunzel, J. F.; De Groote, S.; Ijzerman, A. P. J. Med. Chem. 2001, 44, 749.
15. Comprehensive Heterocyclic Chemistry I; Metzger, J. V., Ed.; Pergamon Press,
1984; Vol. 6, p 328.
16. Kazzouli, S. E.; Raboin, S. B.; Mouadbib, A.; Guillaumet, G. Tetrahedron Lett.
2002, 43, 3193.
N-(3,4-Difluorophenyl)-4-phenylthiazol-2-amine (Table 2, entry 6): Solid, mp
103–105 °C. 1H NMR (DMSO-d6, 300 MHz): d 9.6 (s, 1H), 8.6 (m, 1H), 7.83 (m,
2H), 7.37 (m, 2H), 6.95–6.89 (m, 3H), 2.56 (s, 1H); 13C NMR (DMSO-d6,
75 MHz): d 162.0, 161.6, 158.8, 146.5, 134.8, 128.6, 123.8, 119.7, 118.9, 112.3,
112.0, 110.3,100.3; ESI-MS (m/z): 289 (M+H)+. Anal. Calcd for (C15H10F2N2S): C,
62.49; H, 3.50; N, 9.72; S, 11.12. Found 62.35; H, 3.43; N, 9.66; S, 11.06.
N-(2-Chloro-6-methoxyphenyl)-4-phenylthiazol-2-amine (Table 2, entry 8): Solid,
mp 130–132 °C. 1H NMR (CDCl3, 300 MHz): d 7.62–7.60 (m, 4H), 7.41–7.32 (m,
6H), 3.66 (s, 3H); 13C NMR (CDCl3, 75 MHz): d: 162.3, 145.3, 133.8, 128.7, 128.2,
127.8, 127.5, 125.6, 120.6, 116.0, 110.2, 101.8, 55.5; ESI-MS (m/z): 312(M+H)+.
Anal. Calcd for (C16H13ClN2OS): C, 60.66; H, 4.14; N, 8.84; S, 10.12. Found C,
60.52; H, 4.09; N, 8.78; S, 10.09.
N-(4-Fluorophenyl)-4-(m-tolyl)thiazol-2-amine (Table 2, entry 10): Solid, mp
105–107 °C. 1H NMR (DMSO-d6, 300 MHz): d 7.59–7.56 (m, 3H), 7.31–7.21 (m,
2H), 7.08–7.07 (m, 1H), 7.01–6.98 (m, 2H), 6.72 (s, 1H), 2.36 (s, 3H), 1.53 (br s,
1H); 13C NMR (DMSO-d6, 75 MHz): d: 160.6, 150.8, 137.9, 136.2, 134.1, 128.5,
126.9, 123.3, 121.0, 116.2, 115.9, 101.0, 21.5; ESI-MS (m/z): 285(M+H)+. Anal.
Calcd for (C16H13FN2S): C, 67.58; H, 4.61; N, 9.85; S, 11.28. Found C, 67.42; H,
4.49; N, 9.74; S, 11.19.
N-(3,4-Difluorophenyl)-4-(4-fluorophenyl)thiazol-2-amine (Table 2, entry 12):
Solid, mp 98–101 °C. 1H NMR (DMSO-d6, 300 MHz): d 9.57 (s, 1H), 8.57–8.51
(m, 1H), 7.68 (s, 1H), 7.60 (m, 1H), 7.52 (m, 1H), 7.36–7.31 (m, 1H), 6.96–6.86
(m, 3H); ESI-MS (m/z): 307(M+H)+. Anal. Calcd for (C15H9F3N2S): C, 58.82; H,
2.96; F, 18.61; N, 9.15; S, 10.47. Found C, 58.71; H, 2.88; N, 9.07; S, 10.38.
N,N-Dimethyl-4-phenyl-1,3-selenazol-2-amine(Table 3, entry 3): Solid, mp
112 °C 1H NMR (CDCl3/DMSO-d6, 300 MHz): d 7.83–7.80 (m, 2H), 7.34–7.19
(m, 4H), 3.16 (s, 6H). 13C NMR (CDCl3/DMSO-d6, 200 MHz): d 128.9, 128.7,
127.3, 127.1, 126.9, 126.8, 105.2, 41.1; ESI-MS (m/z): 253(M+H)+. Anal. Calcd
for (C11H12N2Se): C, 52.60; H, 4.82; N, 11.15. Found C, 52.50; H, 4.77; N, 11.12.
N,N-Dimethyl-4-(naphthalen-2-yl)-1,3-selenazol-2-amine (Table 3, entry 4):
Solid, mp 118–120 °C. 1H NMR (CDCl3/DMSO-d6, 300 MHz): d 7.03–7.00 (m,
2H), 6.72–6.67 (m, 4H), 6.55–6.38 (m, 2H), 2.32 (s, 6H). 13C NMR (CDCl3/DMSO-
d6, 200 MHz): d: 128.4, 127.9, 127.8, 127.3, 126.4, 105.1, 41.0; ESI-MS (m/z):30
(M+H)+. Anal. Calcd for (C15H14N2Se): C, 59.81; H, 4.68; N, 9.30. Found C, 59.70;
H, 4.59; N, 9. 23.
17. (a) Bailey, N.; Dean, A. W.; Judd, D. B.; Middlemiss, D.; Storer, R.; Stephen, P. W.
Bioorg. Med. Chem. Lett. 1996, 6, 1409; (b) Kearney, P. C.; Fernandez, M.;
Flygare, J. A. J. Org. Chem. 1998, 62, 196; (c) Goff, D.; Fernandez, J. Tetrahedron
Lett. 1999, 40, 423.
18. (a) Narender, M.; Somi Reddy, M.; Kumar, V. P.; Reddy, V. P.; Nageswar, Y. V. D.;
Rao, K. R. J. Org. Chem. 2007, 72, 1849; (b) Narender, M.; Somi Reddy, M.;
Sridhar, R.; Nageswar, Y. V. D.; Rao, K. R. Tetrahedron Lett. 2005, 46, 5953.